Interestingly, in another hormone-related cancer, breast cancer, overexpression of DDB2 has been reported in tumors of the non-invasive type [20] and another study demonstrated that the expression of DDB2 is higher in ER-positive than ER-negative breast tumors [47]. Here, DDB2 is linked to breast carcinoma.